dc.contributor.author | Mbaveng, Armelle T | |
dc.contributor.author | Omosa, Leonidah K | |
dc.contributor.author | Bitchagno, Gabin T.M | |
dc.contributor.author | Kuete, Jenifer R.N | |
dc.contributor.author | Nchiozem-Ngnitedem, Vaderament-A | |
dc.contributor.author | Kuete, Victor | |
dc.date.accessioned | 2023-05-22T05:50:59Z | |
dc.date.available | 2023-05-22T05:50:59Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Mbaveng AT, Omosa LK, Omosa LK, Kuete JR, Nchiozem-Ngnitedem VA, Kuete V. "Potential antibacterial pharmaceuticals from the flora of Africa.". In: Advances in Botanical Research . https://doi.org/10.1016/bs.abr.2022.08.021: Elsevier; 2022. | en_US |
dc.identifier.uri | http://erepository.uonbi.ac.ke/handle/11295/163634 | |
dc.description.abstract | The present chapter highlights the antibacterial potential of nine highly active
compounds isolated from the African medicinal plants: 8,8-bis-(dihydroconiferyl)-
diferulate, buesgenine, candidone, diospyrone, ferruginin A, isobavachalcone, neo-
bavaisoflavone, neocyclomorusin, and plumbagin. Their botanical source as well as
their hypothetical biosynthetic pathways have also been discussed. Regarding their
inhibitory potential towards the Gram-negative and Gram-positive bacteria, and
mycobacteria, the above phytochemicals constitute potential pharmaceuticals that
deserve clinical studies to develop antibacterial drugs to combat bacterial infections
involving both drug-sensitive and drug-resistant phenotypes. | en_US |
dc.language.iso | en | en_US |
dc.publisher | University of Nairobi | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.title | Potential Antibacterial Pharmaceuticals From the Flora of Africa | en_US |
dc.type | Article | en_US |